3B Pharmaceuticals Gmbh

3B Pharmaceuticals Gmbh company information, Employees & Contact Information

3B Pharmaceuticals GmbH (3BP) is a privately held pharmaceutical R&D company based in Berlin, Germany. The company is dedicated to the development of targeted radiopharmaceutical therapeutics and diagnostics for oncology indications with a high unmet medical need.

Company Details

Employees
57
Founded
-
Address
Magnusstrasse, 11,germany
Phone
+49 (0)30 / 63 92 - 43 17
Email
in****@****rma.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Berlin, Berlin
Looking for a particular 3B Pharmaceuticals Gmbh employee's phone or email?

3b Pharmaceuticals Gmbh Questions

News

Merck grows again in Va. with $3B small-molecule drug plant, part of planned $70B US outlay - Fierce Pharma

Merck grows again in Va. with $3B small-molecule drug plant, part of planned $70B US outlay Fierce Pharma

Merck Begins Construction of $3B Manufacturing Facility in VA - Contract Pharma

Merck Begins Construction of $3B Manufacturing Facility in VA Contract Pharma

ARTBIO to Enter into Licensing and Research Partnership with 3B Pharmaceuticals to Advance a First-in-Class Alpha Radioligand Therapy for Solid Tumors - PR Newswire

ARTBIO to Enter into Licensing and Research Partnership with 3B Pharmaceuticals to Advance a First-in-Class Alpha Radioligand Therapy for Solid Tumors PR Newswire

ASCO25: Actuate flexes survival benefit of front-line elraglusib in mid-stage pancreatic cancer study - FirstWord Pharma

ASCO25: Actuate flexes survival benefit of front-line elraglusib in mid-stage pancreatic cancer study FirstWord Pharma

Merck joins Big Pharma cost-cutting crowd, revealing plan to save $3B annually by 2027 - Fierce Pharma

Merck joins Big Pharma cost-cutting crowd, revealing plan to save $3B annually by 2027 Fierce Pharma

RefleXion acquires radiopharmaceutical rights from 3B Pharmaceuticals - AuntMinnie

RefleXion acquires radiopharmaceutical rights from 3B Pharmaceuticals AuntMinnie

Novartis in US$465m deal with 3B Pharmaceuticals GmbH - European Biotechnology Magazine

Novartis in US$465m deal with 3B Pharmaceuticals GmbH European Biotechnology Magazine

3BP, Novartis enter into deal for FAP-targeting peptide technology - Pharmaceutical Technology

3BP, Novartis enter into deal for FAP-targeting peptide technology Pharmaceutical Technology

Novartis pens $425M biobucks deal with German biotech, scooping up more radiopharmaceutical tech - Fierce Biotech

Novartis pens $425M biobucks deal with German biotech, scooping up more radiopharmaceutical tech Fierce Biotech

Merck will lay off 6,000, reducing workforce by 8% in cost-cutting purge - Fierce Pharma

Merck will lay off 6,000, reducing workforce by 8% in cost-cutting purge Fierce Pharma

Bristol makes its radiopharma move | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Bristol makes its radiopharma move | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

Novartis strikes $425M deal with 3BP for FAP-targeting peptide technology - Medical Marketing and Media

Novartis strikes $425M deal with 3BP for FAP-targeting peptide technology Medical Marketing and Media

Amid industry's onshoring push, Regeneron taps Fujifilm Diosynth for $3B, 10-year commercial manufacturing team-up - Fierce Pharma

Amid industry's onshoring push, Regeneron taps Fujifilm Diosynth for $3B, 10-year commercial manufacturing team-up Fierce Pharma

Clovis offloads targeted radionuclide therapy to Novartis, files for bankruptcy - FirstWord Pharma

Clovis offloads targeted radionuclide therapy to Novartis, files for bankruptcy FirstWord Pharma

At odds with largest shareholder, Bavarian Nordic agrees to $3B buyout by Nordic and Permira - Fierce Pharma

At odds with largest shareholder, Bavarian Nordic agrees to $3B buyout by Nordic and Permira Fierce Pharma

Fierce Pharma Asia—Enhertu's first-line win; Akeso bispecific's positive readout; Regeneron, Fujifilm's $3B deal - Fierce Pharma

Fierce Pharma Asia—Enhertu's first-line win; Akeso bispecific's positive readout; Regeneron, Fujifilm's $3B deal Fierce Pharma

On an investment spree, Lilly will spend $3B to expand newly acquired injectables plant in Wisconsin - Fierce Pharma

On an investment spree, Lilly will spend $3B to expand newly acquired injectables plant in Wisconsin Fierce Pharma

Novo Nordisk expands Ozempic's turf with new FDA nod to curb kidney disease risks - Fierce Pharma

Novo Nordisk expands Ozempic's turf with new FDA nod to curb kidney disease risks Fierce Pharma

In boost to GSK's £3B plan for Blenrep, myeloma ADC shows survival edge over J&J's Darzalex - Fierce Pharma

In boost to GSK's £3B plan for Blenrep, myeloma ADC shows survival edge over J&J's Darzalex Fierce Pharma

From market withdrawal back to £3B peak sales: GSK dreams big for myeloma ADC Blenrep - Fierce Pharma

From market withdrawal back to £3B peak sales: GSK dreams big for myeloma ADC Blenrep Fierce Pharma

Amgen Invests $3B to Expand Mfg. Facility in North Carolina - Contract Pharma

Amgen Invests $3B to Expand Mfg. Facility in North Carolina Contract Pharma

BioNTech, with partner Pfizer, on track to make 3B COVID vaccine doses in 2021, CEO says - Fierce Pharma

BioNTech, with partner Pfizer, on track to make 3B COVID vaccine doses in 2021, CEO says Fierce Pharma

Bayer hikes Nubeqa's peak sales to more than €3B on prostate cancer data, teeing up new 3-way battle against Pfizer-Astellas, J&J - Fierce Pharma

Bayer hikes Nubeqa's peak sales to more than €3B on prostate cancer data, teeing up new 3-way battle against Pfizer-Astellas, J&J Fierce Pharma

Pharma shells out $3B to doctors and hospitals—with Roche, Sanofi leading: CMS - Fierce Pharma

Pharma shells out $3B to doctors and hospitals—with Roche, Sanofi leading: CMS Fierce Pharma

Novartis, Ratio sign radiopharmaceutical pact to the tune of $745M biobucks - Fierce Biotech

Novartis, Ratio sign radiopharmaceutical pact to the tune of $745M biobucks Fierce Biotech

Quarterly sales of Sanofi’s Dupixent cross €3B for the first time - FirstWord Pharma

Quarterly sales of Sanofi’s Dupixent cross €3B for the first time FirstWord Pharma

Eli Lilly lifts sales guidance by $3B as supplies of Mounjaro and Zepbound recover - Fierce Pharma

Eli Lilly lifts sales guidance by $3B as supplies of Mounjaro and Zepbound recover Fierce Pharma

Teva's stunning list of cuts targets 14K jobs, $3B in costs and plants around the globe - Fierce Pharma

Teva's stunning list of cuts targets 14K jobs, $3B in costs and plants around the globe Fierce Pharma

JPM23: Bayer hikes sales targets for Kerendia, Nubeqa to $3B each - Fierce Pharma

JPM23: Bayer hikes sales targets for Kerendia, Nubeqa to $3B each Fierce Pharma

AstraZeneca touts 'overwhelming' Tagrisso win among 3 lung cancer portfolio advancements - Fierce Pharma

AstraZeneca touts 'overwhelming' Tagrisso win among 3 lung cancer portfolio advancements Fierce Pharma

Gilead's $3B Truvada will face generics a year early. Can Descovy still win over its patients? - Fierce Pharma

Gilead's $3B Truvada will face generics a year early. Can Descovy still win over its patients? Fierce Pharma

Sanofi, AZ's blockbuster hopeful RSV med nears first approval as showdown with Pfizer, GSK looms - Fierce Pharma

Sanofi, AZ's blockbuster hopeful RSV med nears first approval as showdown with Pfizer, GSK looms Fierce Pharma

Viatris weighs $3B sale of European consumer drugs amid larger $9B offloading effort: Bloomberg - Fierce Pharma

Viatris weighs $3B sale of European consumer drugs amid larger $9B offloading effort: Bloomberg Fierce Pharma

Bristol Myers joins AstraZeneca, Merck in touting positive lung cancer drug use around surgery - Fierce Pharma

Bristol Myers joins AstraZeneca, Merck in touting positive lung cancer drug use around surgery Fierce Pharma

ESMO: AZ, Daiichi build case for Enhertu in breast cancer patients with brain metastases - Fierce Pharma

ESMO: AZ, Daiichi build case for Enhertu in breast cancer patients with brain metastases Fierce Pharma

Concordia reports $1.3B loss after taking $1.1B write-off on pressured generics - Fierce Pharma

Concordia reports $1.3B loss after taking $1.1B write-off on pressured generics Fierce Pharma

AstraZeneca's Tagrisso, aiming for $3B in sales, trounces chemo in new phase 3 trial - Fierce Pharma

AstraZeneca's Tagrisso, aiming for $3B in sales, trounces chemo in new phase 3 trial Fierce Pharma

Teva to move global HQ to Tel Aviv amid $3B cost-cutting drive - Fierce Pharma

Teva to move global HQ to Tel Aviv amid $3B cost-cutting drive Fierce Pharma

Roche wraps up $4.3B Spark buyout as FTC thumbs-up ends antitrust ordeal - Fierce Pharma

Roche wraps up $4.3B Spark buyout as FTC thumbs-up ends antitrust ordeal Fierce Pharma

Eli Lilly's Kisunla wins FDA nod for new dosing with fewer side effects in Alzheimer's - Fierce Pharma

Eli Lilly's Kisunla wins FDA nod for new dosing with fewer side effects in Alzheimer's Fierce Pharma

UroGen Pharma Announces Publication of Phase 3b Study on At-Home Administration of ZUSDURI™ for Bladder Cancer Treatment - Quiver Quantitative

UroGen Pharma Announces Publication of Phase 3b Study on At-Home Administration of ZUSDURI™ for Bladder Cancer Treatment Quiver Quantitative

With its €5.3B buyout scuppered, Stada brings in new CEO, CFO - Fierce Pharma

With its €5.3B buyout scuppered, Stada brings in new CEO, CFO Fierce Pharma

ACC: Amgen's Repatha cuts cholesterol in rarely studied HIV patients - Fierce Pharma

ACC: Amgen's Repatha cuts cholesterol in rarely studied HIV patients Fierce Pharma

Samsung buys Biogen out of biosimilar unit for $2.3B—not the whole Aduhelm headache - Fierce Pharma

Samsung buys Biogen out of biosimilar unit for $2.3B—not the whole Aduhelm headache Fierce Pharma

Top 20 biotech startups raise $2.9B in Q1 2024 funding surge - drugdiscoverytrends.com

Top 20 biotech startups raise $2.9B in Q1 2024 funding surge drugdiscoverytrends.com

Radiopharmaceutical company Convergent closes series A to the tune of $90M - Fierce Biotech

Radiopharmaceutical company Convergent closes series A to the tune of $90M Fierce Biotech

Fresenius' $4.3B buyout of Akorn threatened by data integrity probe - Fierce Pharma

Fresenius' $4.3B buyout of Akorn threatened by data integrity probe Fierce Pharma

In heavyweight obesity fight, Eli Lilly launches Mounjaro head-to-head trial against Novo Nordisk's Wegovy - Fierce Pharma

In heavyweight obesity fight, Eli Lilly launches Mounjaro head-to-head trial against Novo Nordisk's Wegovy Fierce Pharma

AAD: AbbVie's Skyrizi clears psoriasis symptoms where Novartis' Cosentyx, Lilly's Taltz couldn't - Fierce Pharma

AAD: AbbVie's Skyrizi clears psoriasis symptoms where Novartis' Cosentyx, Lilly's Taltz couldn't Fierce Pharma

AbbVie's Skyrizi delivers head-to-head win versus Amgen's Otezla in psoriasis - Fierce Pharma

AbbVie's Skyrizi delivers head-to-head win versus Amgen's Otezla in psoriasis Fierce Pharma

PAREXEL Names New CEO - Contract Pharma

PAREXEL Names New CEO Contract Pharma

Best way for Teva to deal with Copaxone threat? Settle, analyst urges - Fierce Pharma

Best way for Teva to deal with Copaxone threat? Settle, analyst urges Fierce Pharma

Roche sees glimmer of hope for $4.3B Spark deal as FTC staff gives thumbs-up: report - Fierce Pharma

Roche sees glimmer of hope for $4.3B Spark deal as FTC staff gives thumbs-up: report Fierce Pharma

Roche forced to extend Spark tender offer as investors sue over $4.3B merger - Fierce Pharma

Roche forced to extend Spark tender offer as investors sue over $4.3B merger Fierce Pharma

Alphabet’s Isomorphic stacks two new deals with Lilly, Novartis worth nearly $3B ahead of JPM - Fierce Biotech

Alphabet’s Isomorphic stacks two new deals with Lilly, Novartis worth nearly $3B ahead of JPM Fierce Biotech

AstraZeneca's Fasenra spares asthma patients from steroid use in large trial - Fierce Pharma

AstraZeneca's Fasenra spares asthma patients from steroid use in large trial Fierce Pharma

Novo Nordisk, following in Lilly's Trulicity footsteps, files higher Ozempic dose for diabetes - Fierce Pharma

Novo Nordisk, following in Lilly's Trulicity footsteps, files higher Ozempic dose for diabetes Fierce Pharma

Sanofi, Regeneron ready to roll with $3B-plus Dupixent approval - Fierce Pharma

Sanofi, Regeneron ready to roll with $3B-plus Dupixent approval Fierce Pharma

Citi Pharma attracts Rs2.3b in IPO - The Express Tribune

Citi Pharma attracts Rs2.3b in IPO The Express Tribune

Europe’s shot at radiopharmaceutical leadership - VC Magazin

Europe’s shot at radiopharmaceutical leadership VC Magazin

Kanyama gets his way with N$1,3b pharma tender - The Namibian -

Kanyama gets his way with N$1,3b pharma tender The Namibian -

Top 3B Pharmaceuticals Gmbh Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant